Package 70377-092-23

Brand: everolimus

Generic: everolimus
NDC Package

Package Facts

Identity

Package NDC 70377-092-23
Digits Only 7037709223
Product NDC 70377-092
Description

4 BLISTER PACK in 1 CARTON (70377-092-23) / 7 TABLET, FOR SUSPENSION in 1 BLISTER PACK

Marketing

Marketing Status
Marketed Since 2026-01-14
Brand everolimus
Generic everolimus
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "38b19b37-504e-24ed-7dbc-8b9f9e3fda0a", "openfda": {"nui": ["N0000175605", "N0000175076", "N0000182141", "N0000182137", "N0000175625", "N0000175624", "N0000175550"], "upc": ["0370377092114", "0370377090110", "0370377091117", "0370377091230", "0370377090233"], "unii": ["9HW64Q8G6G"], "rxcui": ["1308428", "1308430", "1308432"], "spl_set_id": ["5b809dfe-c076-07c5-207e-178c3f0d32d3"], "pharm_class_pe": ["Decreased Immunologic Activity [PE]"], "pharm_class_epc": ["Kinase Inhibitor [EPC]", "mTOR Inhibitor Immunosuppressant [EPC]"], "pharm_class_moa": ["Protein Kinase Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "mTOR Inhibitors [MoA]"], "manufacturer_name": ["Biocon Pharma Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "28 TABLET, FOR SUSPENSION in 1 BOTTLE (70377-092-11)", "package_ndc": "70377-092-11", "marketing_start_date": "20260114"}, {"sample": false, "description": "4 BLISTER PACK in 1 CARTON (70377-092-23)  / 7 TABLET, FOR SUSPENSION in 1 BLISTER PACK", "package_ndc": "70377-092-23", "marketing_start_date": "20260114"}], "brand_name": "Everolimus", "product_id": "70377-092_38b19b37-504e-24ed-7dbc-8b9f9e3fda0a", "dosage_form": "TABLET, FOR SUSPENSION", "pharm_class": ["Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Decreased Immunologic Activity [PE]", "Kinase Inhibitor [EPC]", "Protein Kinase Inhibitors [MoA]", "mTOR Inhibitor Immunosuppressant [EPC]", "mTOR Inhibitors [MoA]"], "product_ndc": "70377-092", "generic_name": "Everolimus", "labeler_name": "Biocon Pharma Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Everolimus", "active_ingredients": [{"name": "EVEROLIMUS", "strength": "5 mg/1"}], "application_number": "ANDA217216", "marketing_category": "ANDA", "marketing_start_date": "20260114", "listing_expiration_date": "20271231"}